IRulya Therapeutics Inc. (IRLA) stock
IRLANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$39.80+0.02 (+0.05%)
Close on Nov 13, 2026Market cap $40.48MP/E –Yield –
IRulya Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
IRulya Therapeutics's total debt was $0 at Sep 30, 2026. For fiscal 2025 it was $18.03M.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.03M | – |
| FY2024 | Dec 31, 2024 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $0 | -100.0% |
| Q2 FY2026 | Jun 30, 2026 | $0 | – |
| Q1 FY2026 | Mar 31, 2026 | $0 | – |
| Q4 FY2025 | Dec 31, 2025 | $18.03M | – |
| Q3 FY2025 | Sep 30, 2025 | $17.52M | – |
| Q4 FY2024 | Dec 31, 2024 | $0 | – |
See a number that looks wrong?